RA
Insider
Robert Andrade
CHIEF FINANCIAL OFFICERRobert Andrade (CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Fennec Pharmaceuticals Inc. (FENC). The largest single filing was $884K of FENC (75,000 sh × $11.78, as filed), executed Aug 27.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$884K
shares × price, as filed
Last traded
Aug 27
Filed Aug 28
Median ADV $2.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $884K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
FENCRecent filings
FENCSALE
Fennec Pharmaceuticals Inc.
View filing →
$884K75,000 sh × $11.78
Exec Aug 27
Filed Aug 28 · 5:42 PM ET